Biotron Limited - Product Pipeline Review - 2014

Published: Jan, 2014 | Pages: 32 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Summary

Global Market Direct's pharmaceuticals report, "Biotron Limited - Product Pipeline Review - 2014" provides data on the Biotron Limited's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Biotron Limited's corporate website, SEC filings, investor presentations and featured press releases, both from Biotron Limited and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Biotron Limited - Brief Biotron Limited overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Biotron Limited human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Biotron Limited with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Biotron Limited's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Biotron Limited's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Biotron Limited in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Biotron Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Biotron Limited.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Biotron Limited and identify potential opportunities in those areas.

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Biotron Limited Snapshot 5
Biotron Limited Overview 5
Key Information 5
Key Facts 5
Biotron Limited - Research and Development Overview 6
Key Therapeutic Areas 6
Biotron Limited - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Biotron Limited - Pipeline Products Glance 10
Biotron Limited - Clinical Stage Pipeline Products 10
Phase II Products/Combination Treatment Modalities 10
Biotron Limited - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
Biotron Limited - Drug Profiles 13
BIT-225 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
BIT-314 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Drug For Dengue 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Drug For Influenza 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Drug For Other Targets 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Biotron Limited - Pipeline Analysis 19
Biotron Limited - Pipeline Products by Therapeutic Class 19
Biotron Limited - Pipeline Products by Target 20
Biotron Limited - Pipeline Products by Route of Administration 21
Biotron Limited - Pipeline Products by Molecule Type 22
Biotron Limited - Pipeline Products by Mechanism of Action 23
Biotron Limited - Recent Pipeline Updates 24
Biotron Limited - Dormant Projects 27
Biotron Limited - Discontinued Pipeline Products 28
Discontinued Pipeline Product Profiles 28
BIT-009 28
Biotron Limited - Company Statement 29
Biotron Limited - Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Appendix 31
Methodology 31
Coverage 31
Secondary Research 31
Primary Research 31
Expert Panel Validation 31
Contact Us 32
Disclaimer 32

List of Tables
Biotron Limited, Key Information 5
Biotron Limited, Key Facts 5
Biotron Limited - Pipeline by Indication, 2014 7
Biotron Limited - Pipeline by Stage of Development, 2014 8
Biotron Limited - Monotherapy Products in Pipeline, 2014 9
Biotron Limited - Phase II, 2014 10
Biotron Limited - Preclinical, 2014 11
Biotron Limited - Discovery, 2014 12
Biotron Limited - Pipeline by Therapeutic Class, 2014 19
Biotron Limited - Pipeline by Target, 2014 20
Biotron Limited - Pipeline by Route of Administration, 2014 21
Biotron Limited - Pipeline by Molecule Type, 2014 22
Biotron Limited - Pipeline Products by Mechanism of Action, 2014 23
Biotron Limited - Recent Pipeline Updates, 2014 24
Biotron Limited - Dormant Developmental Projects,2014 27
Biotron Limited - Discontinued Pipeline Products, 2014 28
Biotron Limited, Other Locations 30